rs35993655
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000558.5(HBA1):c.389T>C(p.Leu130Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000657 in 152,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000558.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000137 AC: 2AN: 1461462Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727042
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74366
ClinVar
Submissions by phenotype
alpha Thalassemia Pathogenic:1
- -
alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693798:Methemoglobinemia, alpha type;C4693823:Erythrocytosis, familial, 7 Pathogenic:1
- -
not provided Pathogenic:1
The Hb Tunis-Bizerte variant (HBA1: c.389T>C; Leu129Pro) (rs35993655), has been described in the heterozygous state in individuals with no clinical presentation, but in the homozygous state in an individual with marked anemia and microcytosis (Darbellay 1995, HbVar database). Based on mass spectrometric analysis of the globins from both a heterozygote and homozygote, these authors concluded that the HBA1 chain harboring Leu129Pro represented <1% of the alpha globin chains and, thus, the variant is associated with a thalassemic phenotype. This variant is listed in ClinVar (Variation ID: 15865), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. Additionally, the corresponding amino acid change in HBA2 (Leu129Pro, Hb Utrecht) is predicted to be very unstable, with heterozygous carriers reported with a mild alpha-thalassemic phenotype (Harteveld 1996, HbVar database). The lysine at codon 129 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Based on available evidence, the Hb Tunis-Bizerte variant is predicted to be likely pathogenic for alpha-thalassemia, although to the best of our knowledge its effect in combination with deletional alpha thalassemia variants is not known. References: Link to HbVar database for Hb Tunis-Bizerte: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=195 Link to HbVar database for Hb Utrecht: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=196&.cgifields=histD Darbellay R et al. Haemoglobin Tunis-Bizerte: a new alpha 1 globin 129 Leu>Pro unstable variant with thalassaemic phenotype. Br J Haematol. 1995 May;90(1):71-6. Harteveld CL et al. Hb Utrecht (alpha 2 129(H12)Leu-->Pro), a new unstable alpha 2-chain variant associated with a mild alpha-thalassaemic phenotype. Br J Haematol. 1996 Sep;94(3):483-5. -
HEMOGLOBIN TUNIS-BIZERTE Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at